The FDA is requesting manufacturers to withdraw all Zantac and generic Zantac OTC Ranitidine drugs from the market. Zantac and its generic version Ranitidine have been shown to create NDMA when taken as indicated. The EPA, World Health Organization, the FDA, and other international health groups all classify NDMA as a known cancer-causing substance.

How can we help?


ZANTAC (Ranitidine) → NDMA → CANCER


What is Zantac?

Zantac (ranitidine hydrochloride) is an H2-receptor antagonist used to treat stomach and intestinal ulcers, GERD, and other stomach and throat problems, including “heartburn”. Manufactured initially under the trade name Zantac, Ranitidine was at one point the highest selling drug in the world. It has been available by prescription and over the counter.

Zantac Lawsuit Investigation

Riley & Jackson is investigating reports of colon, GI, stomach, liver, bladder, pancreatic, and other cancers caused by Zantac. Pharmaceutical studies have shown that Zantac when taken as intended causes a chemical reaction that creates NDMA within the human body at levels that far exceed what could arguably be safe. Zantac manufacturer Sanofi is facing allegations that it knew that Zantac would cause the creation of NDMA, which in turn can cause cancer, but failed to warn patients that Zantac may cause cancer. These allegations are that Sanofi concealed the truth from millions of patients while making extraordinary profits from Zantac, which was the first drug to generate over $1 billion in sales.

For more information, please call 205-879-5000 or send us an e-mail

    Disclaimer: The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.